MARKET

NEOG

NEOG

Neogen Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.68
+0.45
+1.72%
After Hours: 26.68 0 0.00% 16:02 05/27 EDT
OPEN
26.45
PREV CLOSE
26.23
HIGH
26.95
LOW
26.29
VOLUME
664.08K
TURNOVER
0
52 WEEK HIGH
47.80
52 WEEK LOW
24.90
MARKET CAP
2.88B
P/E (TTM)
58.83
1D
5D
1M
3M
1Y
5Y
Does The Market Have A Low Tolerance For Neogen Corporation's (NASDAQ:NEOG) Mixed Fundamentals?
With its stock down 28% over the past three months, it is easy to disregard Neogen (NASDAQ:NEOG). We, however decided...
Simply Wall St. · 1d ago
Neogen® Launches Enhanced Quantitative Peanut ELISA Assay
Neogen® Corporation (NASDAQ: NEOG) announced today that the company has released an enhanced version of the Veratox® for Peanut allergen test, which optimizes sensitivity and flexibility across sample types while maintaining the rapid time-to-result and si...
PR Newswire · 05/18 12:45
NEOGEN (NEOG) Introduces InfiniSEEK for Cattle Breeders
NEOGEN's (NEOG) recent launch enables simultaneous low-pass whole genome sequencing and high-coverage genotyping at regions of interest.
Zacks · 05/13 14:22
BRIEF-Neogen And Gencove Launch InfiniSEEK
reuters.com · 05/12 12:47
NEOGEN® and Gencove Launch InfiniSEEK™ -- The First Whole Genome and Genotyping Sequencing Solution for Cattle Breeders
NEOGEN® Corporation (NASDAQ: NEOG) and Gencove, the leading low-pass whole genome sequencing and analysis software company, today announced the launch of InfiniSEEK™, an innovative, cost-effective solution for whole genome sequencing and targeted SNP analy...
PR Newswire · 05/12 12:45
Quite a few insiders invested in Neogen Corporation (NASDAQ:NEOG) last year which is positive news for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Simply Wall St. · 05/04 14:29
NEOGEN And FOCO Highlights Collaboration On Epigenetic Research Project
The companies utilized data collected in the Physicians' Health Study to pioneer landmark research for longevity science LINCOLN, Neb., April 29, 2022 /PRNewswire/ -- NEOGEN Corporation (NASDAQ:NEOG) and FOXO
Benzinga · 04/29 12:49
NEOGEN and FOXO Technologies Combine on Epigenetic Research Project
NEOGEN Corporation (NASDAQ: NEOG) and FOXO Technologies, Inc. ("FOXO") — a technology company applying epigenetic science and AI to modernize the life insurance industry — collaborated on an extensive research project examining the association between epig...
PR Newswire · 04/29 12:45
More
No Data
Learn about the latest financial forecast of NEOG. Analyze the recent business situations of Neogen Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average NEOG stock price target is 55.00 with a high estimate of 55.00 and a low estimate of 55.00.
High55.00
Average55.00
Low55.00
Current 26.68
EPS
Actual
Estimate
0.040.090.130.17
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 431
Institutional Holdings: 103.97M
% Owned: 96.43%
Shares Outstanding: 107.82M
TypeInstitutionsShares
Increased
104
2.16M
New
47
1.71M
Decreased
106
3.11M
Sold Out
23
692.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Non-Executive Chairman/Lead Director/Independent Director
James Borel
President/Chief Executive Officer/Director
John Adent
Chief Financial Officer/Vice President
Steven Quinlan
Chief Operating Officer
Doug Jones
Vice President
Jerome Hagedorn
Vice President
Jason Lilly
Independent Director
William Boehm
Independent Director
Ronald Green
Independent Director
Ralph Rodriguez
Independent Director
James Tobin
Independent Director
Darci Vetter
Independent Director
Catherine Woteki
No Data
No Data
About NEOG
Neogen Corporation is a developer, manufacturer, and marketer of a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits, culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides.

Webull offers kinds of Neogen Corporation stock information, including NASDAQ:NEOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NEOG stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NEOG stock methods without spending real money on the virtual paper trading platform.